ANNA PAYLOR: Open Payments
NPI 1134654056 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,693 in 158 payments from 30 companies in 2025. Trend: 2023 $1,463 · 2024 $2,535 · 2025 $3,693
Food & beverage: $3,250Consulting: $350Education: $94
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $633 |
| GlaxoSmithKline, LLC. | 28 | $373 |
| Regeneron Healthcare Solutions, Inc. | 15 | $295 |
| JAZZ PHARMACEUTICALS INC. | 6 | $280 |
| GENZYME CORPORATION | 11 | $262 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $243 |
| United Therapeutics Corporation | 7 | $165 |
| Axsome Therapeutics, Inc. | 6 | $161 |
| Verona Pharma, Inc. | 8 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $138 |
Products named: DUPIXENT, XYWAV, LUMRYZ, NUCALA, TEZSPIRE, Tyvaso, Sunosi, BREZTRI.
Industry payments across NC — which companies pay providers there.
